Showing all 4 results
UPA Maglira 5mg Pen Semaglutide
R1600,00The UPA Maglira 5mg Pen is a premium, prefilled injectable designed to help regulate appetite, manage blood sugar, and support steady, sustainable fat loss. Powered by Liraglutide, a clinically proven GLP-1 analogue, Maglira works by mimicking the body’s natural satiety hormone – reducing hunger, slowing gastric emptying, and promoting long-term weight management without extreme diets or routines.
UPA Magtidelira PEN 33mg NEW HYBRID
R2900,00The UPA Maglira 5mg Pen is a premium, prefilled injectable designed to help regulate appetite, manage blood sugar, and support steady, sustainable fat loss. Powered by Liraglutide, a clinically proven GLP-1 analogue, Maglira works by mimicking the body’s natural satiety hormone – reducing hunger, slowing gastric emptying, and promoting long-term weight management without extreme diets or routines.
UPA Maglira is a high-quality Liraglutide-based injectable solution developed for weight loss and appetite control.UPA Retlira 30mg Pen – Retatrutide
Original price was: R2700,00.R2500,00Current price is: R2500,00.RETLIRA is a powerful triple-action peptide therapy containing 30mg of Retatrutide, a new-generation weight loss compound targeting:
GLP-1 receptors – reduces appetite and stabilizes blood sugar
GIP receptors – improves insulin sensitivity
Glucagon receptors – boosts fat burning and metabolism
RETLIRA mimics three key metabolic hormones in one weekly injection,
outperforming older GLP-1 options like Semaglutide and Tirzepatide.UPA Tidlira 30mg Pen – Tirzepatide
R2000,00TIDLIRA™ is a next-generation injectable treatment powered by Tirzepatide, a breakthrough dual receptor agonist that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. This dual action helps regulate blood sugar, control appetite, and promote significant, sustainable weight loss.
